{
  "main_header": {
    "sid": 256229,
    "name": "Wockhardt",
    "stock_name": "Wockhardt",
    "full_name": "Wockhardt Ltd",
    "name_url": "stocks-analysis/wockhardt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,410.55",
    "chg": 30.85,
    "chgp": "2.24%",
    "dir": 1,
    "prev_price": "1,379.70",
    "mcapval": "23,689.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532300,
    "symbol": "WOCKPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE049B01025",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "41.5 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/wockhardt-256229-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Wockhardt falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-wockhardt-fallingrising-3764228",
        "imagepath": "",
        "date": "2025-12-20 02:14:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Context</strong></p>\n<p>Wockhardt’s shares have demonstrated notable resilience in recent trading sessions, gaining 5.13% over the past week and 6.01% in the last month, significantly outperforming the Sensex which declined marginally over the same periods. The stock has recorded a four-day consecutive gain, delivering a 5.28% return in this short span. Intraday, the share price touched a high of ₹1,484.85, marking a 7.62% increase from previous levels, signalling strong buying interest. Despite this, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting some profit-taking or cautious positioning among traders.</p>\n<p>Technically, the stock is trading above its 5-day, 20-day, and 50-day moving averag..."
      },
      {
        "title": "Wockhardt Sees Robust Trading Activity Amidst Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-surges-on-heavy-value-trading-amid-institutional-interest-3763900",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_most_active_equities_by_value_3763900.png",
        "date": "2025-12-19 11:00:09",
        "description": "Wockhardt Ltd has emerged as one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector, demonstrating notable investor interest and liquidity on 19 Dec 2025. The stock's performance today reflects a significant divergence from sector and benchmark indices, supported by strong trading volumes and a rising price trend over recent sessions."
      },
      {
        "title": "Wockhardt’s Evaluation Metrics Revised Amid Mixed Financial and Market Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/wockhardt-upgraded-from-strong-sell-to-sell-by-marketsmojo-on-1-dec-2025-3759913",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_mojoScore_3759913.png",
        "date": "2025-12-16 10:10:19",
        "description": "Wockhardt’s recent assessment has been revised, reflecting nuanced shifts across key analytical parameters. The pharmaceutical company’s financial trend shows encouraging signs, while valuation and technical indicators present a more cautious outlook, underscoring the complexity of its current market position."
      },
      {
        "title": "Wockhardt Sees Elevated Trading Activity Amidst Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-surges-on-high-value-trading-amid-sector-outperformance-and-institutional-interest-3748430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_most_active_equities_by_value_3748430.png",
        "date": "2025-12-05 10:00:07",
        "description": "Wockhardt Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, recorded significant trading volumes and value turnover on 5 December 2025, reflecting heightened market interest. The stock outperformed its sector peers and demonstrated a notable intraday price movement, signalling renewed investor focus amid a fluctuating market environment."
      },
      {
        "title": "Is Wockhardt overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wockhardt-overvalued-or-undervalued-3745150",
        "imagepath": "",
        "date": "2025-12-04 08:11:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Examining Wockhardt’s Valuation Metrics</strong></p>\n<p>Wockhardt’s price-to-earnings (PE) ratio stands at an extraordinary 310.7, far exceeding typical industry standards and signalling a premium valuation. This figure dwarfs the PE ratios of many peers, including Sun Pharma Industries and Divi’s Laboratories, which themselves are considered expensive or very expensive. The company’s price-to-book value of 5.04 also suggests investors are paying a significant premium over its net asset value.</p>\n<p>Enterprise value multiples further highlight the stretched valuation. The EV to EBIT ratio is 108.98, and EV to EBITDA is 55.48, both substantially higher than industry averages. These elevated multiples imply that the market expects robust future earnings growth or unique competitive advantages..."
      },
      {
        "title": "Wockhardt Sees Robust Trading Activity Amidst Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-surges-on-heavy-value-trading-and-institutional-interest-amid-sector-outperformance-3741225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_most_active_equities_by_value_3741225.png",
        "date": "2025-12-02 10:00:09",
        "description": "Wockhardt Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 2 December 2025. The stock demonstrated notable trading volumes and value turnover, outperforming its sector peers and reflecting heightened investor interest and liquidity in the market."
      },
      {
        "title": "Is Wockhardt technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wockhardt-technically-bullish-or-bearish-3739991",
        "imagepath": "",
        "date": "2025-12-02 08:24:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Recent Price Movements</strong></p>\n<p>Wockhardt’s current market price stands at ₹1,470.90, having surged from a previous close of ₹1,233.55. The stock’s intraday range on the latest trading session was between ₹1,226.15 and ₹1,480.25, indicating notable volatility. Over the past 52 weeks, the share price has oscillated between a low of ₹1,109.60 and a high of ₹1,870.00, reflecting a broad trading band that investors should consider when evaluating risk and reward.</p>\n<p><strong>Technical Trend Shift: From Bearish to Mildly Bearish</strong></p>\n<p>As of 1 December 2025, Wockhardt’s overall technical trend has transitioned from bearish to mildly bearish. This subtle shift suggests that while the stock remains under some selling pressure, the intensity of bearish momentum has eas..."
      },
      {
        "title": "Wockhardt Stock Analysis: Technical Momentum and Market Assessment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-shares-surge-amid-mixed-technical-signals-and-momentum-shift-3739925",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_technicaldot_3739925.png",
        "date": "2025-12-02 08:02:47",
        "description": "Wockhardt’s recent trading activity reveals a notable shift in technical momentum, with key indicators signalling a transition from a bearish stance to a more nuanced mildly bearish outlook. The stock’s price movement, combined with mixed signals from MACD, RSI, and moving averages, offers investors a complex picture amid a volatile market backdrop."
      },
      {
        "title": "How has been the historical performance of Wockhardt?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-wockhardt-3739168",
        "imagepath": "",
        "date": "2025-12-01 23:00:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Operating Performance Trends</strong></p>\n<p>Wockhardt's net sales have experienced variability, with figures peaking at ₹3,565 crore in March 2019 before declining and fluctuating in subsequent years. The fiscal year ending March 2025 recorded net sales of ₹3,012 crore, reflecting a modest recovery from the previous year’s ₹2,798 crore. This oscillation in revenue highlights the competitive pressures and market dynamics faced by the pharmaceutical company.</p>\n<p>Operating profit margins excluding other income have shown a gradual improvement, reaching 13.05% in March 2025 compared to a low of 1.39% in the prior year. The operating profit (PBDIT) excluding other income rose significantly to ₹393 crore in the latest fiscal year from ₹39 crore in March 2024, signalling enhanced op..."
      }
    ],
    "total": 379,
    "sid": "256229",
    "stock_news_url": "https://www.marketsmojo.com/news/wockhardt-256229"
  },
  "announcements": [
    {
      "caption": "Intimation For Incorporation Of Step-Down Subsidiaries Of The Company.",
      "datetime": "16-Dec-2025",
      "details": "Pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 we hereby inform you that Wockhardt Bio AG a Subsidiary of the Company has incorporated three new Wholly Owned Subsidiaries Wockhardt Swiss AG (Switzerland) Wockhardt Suisse USA Holding Corporation (USA) and Wockhardt Suisse USA LLC (USA). Consequent to the Incorporation Wockhardt Swiss AG Wockhardt Suisse USA Holding Corporation and Wockhardt Suisse USA LLC have become Step- Down Subsidiaries of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "15-Dec-2025",
      "details": "Pursuant to Regulation 44 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the Voting Results of the Postal Ballot along with Scrutinizers Report dated 15th December 2025",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "15-Dec-2025",
      "details": "Pursuant to Regulation 44 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the Voting Results of Postal Ballot along with Scrutinizers Report dated 15th December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has declared <strong>200%</strong> dividend, ex-date: 17 Nov 16",
          "dt": "2016-11-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has announced <strong>3:10</strong> rights issue, ex-date: 08 Mar 22",
          "dt": "2022-03-08",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Why is Wockhardt falling/rising?

2025-12-20 02:14:39

Recent Price Performance and Market Context

Wockhardt’s shares have demonstrated notable resilience in recent trading sessions, gaining 5.13% over the past week and 6.01% in the last month, significantly outperforming the Sensex which declined marginally over the same periods. The stock has recorded a four-day consecutive gain, delivering a 5.28% return in this short span. Intraday, the share price touched a high of ₹1,484.85, marking a 7.62% increase from previous levels, signalling strong buying interest. Despite this, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting some profit-taking or cautious positioning among traders.

Technically, the stock is trading above its 5-day, 20-day, and 50-day moving averag...

Read More

Wockhardt Sees Robust Trading Activity Amidst Sector Outperformance

2025-12-19 11:00:09

Wockhardt Ltd has emerged as one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector, demonstrating notable investor interest and liquidity on 19 Dec 2025. The stock's performance today reflects a significant divergence from sector and benchmark indices, supported by strong trading volumes and a rising price trend over recent sessions.

Read More

Wockhardt’s Evaluation Metrics Revised Amid Mixed Financial and Market Signals

2025-12-16 10:10:19

Wockhardt’s recent assessment has been revised, reflecting nuanced shifts across key analytical parameters. The pharmaceutical company’s financial trend shows encouraging signs, while valuation and technical indicators present a more cautious outlook, underscoring the complexity of its current market position.

Read More

Wockhardt Sees Elevated Trading Activity Amidst Sector Outperformance

2025-12-05 10:00:07

Wockhardt Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, recorded significant trading volumes and value turnover on 5 December 2025, reflecting heightened market interest. The stock outperformed its sector peers and demonstrated a notable intraday price movement, signalling renewed investor focus amid a fluctuating market environment.

Read More

Is Wockhardt overvalued or undervalued?

2025-12-04 08:11:24

Examining Wockhardt’s Valuation Metrics

Wockhardt’s price-to-earnings (PE) ratio stands at an extraordinary 310.7, far exceeding typical industry standards and signalling a premium valuation. This figure dwarfs the PE ratios of many peers, including Sun Pharma Industries and Divi’s Laboratories, which themselves are considered expensive or very expensive. The company’s price-to-book value of 5.04 also suggests investors are paying a significant premium over its net asset value.

Enterprise value multiples further highlight the stretched valuation. The EV to EBIT ratio is 108.98, and EV to EBITDA is 55.48, both substantially higher than industry averages. These elevated multiples imply that the market expects robust future earnings growth or unique competitive advantages...

Read More

Wockhardt Sees Robust Trading Activity Amidst Sector Outperformance

2025-12-02 10:00:09

Wockhardt Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 2 December 2025. The stock demonstrated notable trading volumes and value turnover, outperforming its sector peers and reflecting heightened investor interest and liquidity in the market.

Read More

Is Wockhardt technically bullish or bearish?

2025-12-02 08:24:29

Overview of Recent Price Movements

Wockhardt’s current market price stands at ₹1,470.90, having surged from a previous close of ₹1,233.55. The stock’s intraday range on the latest trading session was between ₹1,226.15 and ₹1,480.25, indicating notable volatility. Over the past 52 weeks, the share price has oscillated between a low of ₹1,109.60 and a high of ₹1,870.00, reflecting a broad trading band that investors should consider when evaluating risk and reward.

Technical Trend Shift: From Bearish to Mildly Bearish

As of 1 December 2025, Wockhardt’s overall technical trend has transitioned from bearish to mildly bearish. This subtle shift suggests that while the stock remains under some selling pressure, the intensity of bearish momentum has eas...

Read More

Wockhardt Stock Analysis: Technical Momentum and Market Assessment

2025-12-02 08:02:47

Wockhardt’s recent trading activity reveals a notable shift in technical momentum, with key indicators signalling a transition from a bearish stance to a more nuanced mildly bearish outlook. The stock’s price movement, combined with mixed signals from MACD, RSI, and moving averages, offers investors a complex picture amid a volatile market backdrop.

Read More

How has been the historical performance of Wockhardt?

2025-12-01 23:00:55

Revenue and Operating Performance Trends

Wockhardt's net sales have experienced variability, with figures peaking at ₹3,565 crore in March 2019 before declining and fluctuating in subsequent years. The fiscal year ending March 2025 recorded net sales of ₹3,012 crore, reflecting a modest recovery from the previous year’s ₹2,798 crore. This oscillation in revenue highlights the competitive pressures and market dynamics faced by the pharmaceutical company.

Operating profit margins excluding other income have shown a gradual improvement, reaching 13.05% in March 2025 compared to a low of 1.39% in the prior year. The operating profit (PBDIT) excluding other income rose significantly to ₹393 crore in the latest fiscal year from ₹39 crore in March 2024, signalling enhanced op...

Read More

View All News